BMEE can reduce hepatic insulin resistance and the same time improve hepatic glucose uptake via the insulin and the NF‐kB signaling pathways by increasing IRS‐1 and GLUT‐2 gene expression while reducing gene expression of NFkB in the liver. The gene discussed is SLC2A2; the disease is Insulin resistance.